Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental pathogenetic definition of acute infantile hemiplegia?	It is a sudden-onset focal neurological deficit characterized by motor weakness involving one side of the body, primarily resulting from cerebrovascular events (ischemic or hemorrhagic) or non-vascular acute central nervous system insults in infants and children.
2. How does the pathophysiology of arterial ischemic stroke in infants differ structurally from that in adults?	Unlike adults where atherosclerosis is paramount, infants frequently experience stroke due to arteriopathies, cardioembolism from congenital heart disease, transient cerebral arteriopathy (TCA), and inherited prothrombotic states.
3. What is the role of the Circle of Willis in determining the anatomical distribution of pediatric ischemic stroke?	The MCA (Middle Cerebral Artery) territory is most commonly affected due to its direct anatomical continuation with the internal carotid artery, making it the highest-resistance pathway for emboli.
4. What are the key cellular pathological steps in the ischemic cascade following vascular occlusion in an infant brain?	1. ATP depletion and failure of Na+/K+ ATPase pumps, 2. Cytotoxic edema, 3. Excitotoxicity via excessive extracellular glutamate influx, 4. Intracellular calcium overload, and 5. Free radical generation leading to delayed neuronal apoptosis.
5. How does the immature neonatal and infant brain respond to hypoxia-ischemia compared to the mature brain?	The immature brain has higher expression of NMDA receptors and lower antioxidant capacity, rendering it exceptionally vulnerable to excitotoxicity, whereas it is relatively more resistant to certain forms of classic white matter necrosis compared to adults.
6. Which genetic mutations are classically linked to familial hemiplegic migraine that can mimic acute infantile hemiplegia?	Mutations in CACNA1A (encoding P/Q type calcium channel alpha-1 subunit), ATP1A2 (sodium-potassium pump alpha-2 subunit), and SCN1A (voltage-gated sodium channel) are classic for familial hemiplegic migraine.
7. What is the underlying molecular pathology of Moyamoya disease predisposing children to both ischemia and hemorrhage?	Progressive stenotic occlusion of the terminal internal carotid arteries and proximal anterior/middle cerebral arteries leads to the development of fragile, collateral net-like vessels (moyamoya vessels) prone to micro-aneurysms and rupture.
8. Name two primary inherited prothrombotic risk factors evaluated in children presenting with acute ischemic stroke.	Factor V Leiden mutation and Prothrombin G20210A gene mutation, alongside deficiencies in natural anticoagulants like Protein C, Protein S, and Antithrombin III.
9. How does primary cerebral sinovenous thrombosis (CSVT) lead to hemiplegia pathophysiologically?	Occlusion of dural sinuses impairs cerebral venous outflow, raising intracranial pressure, causing venous infarction, secondary ischemia, and frequently hemorrhagic transformation of the affected parenchyma.
10. What is the classification of acute infantile hemiplegia based on primary vascular versus non-vascular etiology?	It is broadly divided into 1. Arterial Ischemic Stroke (AIS), 2. Cerebral Sinovenous Thrombosis (CSVT), 3. Intracranial Hemorrhage (ICH), and 4. Non-vascular mimics (e.g., Hemiplegic migraine, Alternating hemiplegia of childhood, Todd's paresis).
11. What distinguishes Alternating Hemiplegia of Childhood (AHC) genetically and pathophysiologically from acute static infantile hemiplegia?	AHC is a rare neurometabolic/neurodevelopmental disorder caused almost exclusively by de novo heterozygous mutations in the ATP1A3 gene, characterized by paroxysmal, recurrent hemiplegic episodes affecting alternating sides.
12. What is the precise pathophysiological mechanism of Todd's paresis following a focal motor seizure?	It involves transient, localized neuronal exhaustion, active metabolic suppression, and hyperpolarization of the motor cortex following intense electrical seizure activity.
13. How do systemic inflammatory and infectious states trigger acute ischemic stroke in infants (arteriopathy-related)?	Systemic pathogens or localized upper respiratory infections induce a pro-inflammatory cytokine surge that triggers endothelial injury, immune-mediated vessel wall inflammation, and localized thrombus formation.
14. VIVA TRAP: N. VIVA TRAP: Can uncomplicated viral infections directly cause a primary cardioembolic stroke in a healthy infant without congenital heart disease?	NO. Viral infections cause arteriopathy or prothrombotic states, but cardioembolism strictly requires an intracardiac source such as structural congenital heart disease, arrhythmias, or endocarditis.
15. What anatomical features explain why hemorrhagic transformation is common in pediatric venous infarcts compared to arterial infarcts?	Venous obstruction leads to diffuse capillary and venular congestion, raised hydrostatic pressure, and subsequent diapedesis of red blood cells across damaged vessel walls.
16. How does neonatal arterial ischemic stroke pathophysiology differ from childhood AIS regarding maternal/placental risk factors?	Neonatal AIS is heavily influenced by placental pathology, chorioamnionitis, emergency obstetric complications, and prothrombotic states unique to the maternal-fetal unit, unlike older children.
17. What is the classification grading scale commonly used to stage pediatric arterial ischemic stroke by anatomical extent?	The Pediatric National Institutes of Health Stroke Scale (PedNIHSS) or Pediatric Stroke Outcome Measure (PSOM) grades neurological severity acutely and functionally at follow-up.

Clinical History & Bedside Evaluation

Question	Answer
1. What is the significance of establishing the exact mode of onset (hyperacute vs. subacute) when evaluating acute infantile hemiplegia?	A hyperacute, stroke-like onset within seconds to minutes typically points to vascular events like arterial ischemic stroke or cardioembolism, whereas a stepwise or subacute progression over days suggests infection, demyelination, or a growing mass lesion.
2. Why is a meticulous history of preceding minor head or neck trauma critical in an infant presenting with acute hemiplegia?	Minor trauma can trigger cervical or intracranial internal carotid artery dissection, which is an increasingly recognized cause of pediatric arterial ischemic stroke.
3. How does inquiring about recent varicella infection within the past 12 months help narrow the etiology of acute infantile hemiplegia?	Post-varicella angiopathy is a classic cause of transient cerebral arteriopathy (TCA) and delayed-onset cerebral infarction in young children.
4. What specific details must be elicited regarding a preceding febrile illness when evaluating an acute hemiplegia presentation?	1. Document the height and duration of fever, 2. Inquire about signs of meningeal irritation or focal CNS infection, and 3. Check for dehydration which can precipitate thrombosis in a hypercoagulable state.
5. What constitutes a differential diagnostic red flag in history when a child presenting with hemiplegia also has systemic symptoms like lethargy and vomiting?	These global CNS symptoms indicate raised intracranial pressure due to extensive edema, venous sinus thrombosis, or an intracranial space-occupying lesion rather than a pure focal vascular infarct.
6. Why must a detailed dietary and nutritional history be obtained in an infant presenting with acute stroke-like symptoms?	Severe nutritional deficiencies (e.g., hyperhomocysteinemia secondary to Vitamin B12 deficiency or iron deficiency anemia) are established metabolic risk factors for cerebral sinovenous thrombosis and stroke in infants.
7. What crucial elements should be covered during the perinatal and birth history of a child evaluated for infantile hemiplegia?	1. History of birth asphyxia or hypoxic-ischemic encephalopathy, 2. Intrapartum complications, 3. Chorioamnionitis or placental abruption, and 4. Neonatal intensive care admission or central line placement.
8. How does a comprehensive developmental history aid in differentiating congenital static hemiplegia from acute acquired infantile hemiplegia?	A history of normal developmental milestones up to the exact moment of the acute event strongly supports an acquired etiology, whereas prior subtle delays point toward a remote perinatal stroke or cerebral malformation.
9. VIVA TRAP: N. VIVA TRAP: Can a history of a brief, self-limiting focal clonic seizure immediately preceding limb weakness be safely ignored when diagnosing acute infantile hemiplegia?	NO. A post-ictal state frequently causes Todd's paresis, which mimics acute structural hemiplegia and requires careful clinical differentiation.
10. What historical clues suggest that an acute hemiplegia presentation is actually a manifestation of alternating hemiplegia of childhood (AHC)?	A history of episodic, recurrent attacks affecting alternating sides of the body, often accompanied by dystonic posturing, autonomic phenomena, and disappearance of symptoms during sleep.
11. What historical indicators point toward a mitochondrial disorder like MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)?	A history of short stature, exercise intolerance, recurrent migraine-like headaches, seizures, and maternal family history of hearing loss or diabetes.
12. How should an examiner document the exact chronological timeline of motor weakness during the bedside history taking?	1. Establish the exact hour and day of onset, 2. Determine if the weakness was maximal at onset or progressive, and 3. Note whether it fluctuated or remained static.
13. What specific medication or drug history must be explored in an adolescent or older child presenting with acute focal neurological deficits?	Inquire about the use of oral contraceptives, illicit substances (such as sympathomimetics or cocaine), or exposure to prothrombotic drugs.
14. What historical feature distinguishes a complex migraine with prolonged aura from acute arterial ischemic stroke?	Migraine aura typically features positive visual or sensory phenomena spreading gradually over 5 to 20 minutes followed by headache, whereas stroke presents with sudden negative neurological deficits like acute weakness.
15. What specific questions should be asked regarding the pattern of extremity involvement (face vs. arm vs. leg) to localize the lesion?	Inquire whether the weakness involves the face and arm predominantly (cortical MCA territory) or equally affects the entire body side (capsular/deep gray matter involvement).
16. What red flags in the social and environmental history should an examiner look for in cases of unexplained acute infantile stroke?	A history of accidental or non-accidental trauma (abusive head trauma) or exposure to environmental toxins/venomous bites.
17. VIVA TRAP: N. VIVA TRAP: Is a negative family history of bleeding or clotting disorders sufficient to rule out an inherited prothrombotic state in a child with stroke?	NO. Many inherited thrombophilias (such as Protein C, Protein S, or Antithrombin deficiencies) present with de novo mutations or autosomal recessive traits that do not show a clear positive family history.
18. What specific history elements and prodromal symptoms help differentiate transient cerebral arteriopathy (TCA) from primary CNS vasculitis or cardioembolic stroke in an infant presenting with acute hemiplegia?	1. Eliciting a history of a recent minor upper respiratory tract infection or varicella exanthem within the preceding weeks points strongly toward post-infectious transient cerebral arteriopathy (TCA). 2. A insidious onset with stepwise progression or recurrent multifocal neurological deficits over months suggests primary CNS vasculitis or moyamoya disease. 3. Conversely, an abrupt, stroke-in-evolution onset without prodromal infection strongly raises suspicion for a cardioembolic source or prothrombotic hematological disorder.

Physical Examination & Bedside Signs

Question	Answer
1. What is the standard methodology for assessing anthropometric parameters during the physical examination of a child with acute infantile hemiplegia?	1. Measure weight, length/height, and head circumference meticulously and plot them on age- and sex-matched WHO growth charts. 2. Chronic failure to thrive or microcephaly points toward a congenital, developmental, or chronic neurodegenerative etiology rather than an isolated acute vascular event.
2. How is the pronator drift sign properly elicited and interpreted in a cooperative young child presenting with acute hemiplegia?	1. Ask the child to hold both arms outstretched forward with palms facing upward and eyes closed for 10 to 30 seconds. 2. Downward drift and pronation of the forearm on the affected side indicate subtle pyramidal tract dysfunction and corticospinal weakness.
3. What specific bedside maneuver is used to evaluate for hypotonia or hypertonia in the upper extremities during the acute versus chronic phase of infantile hemiplegia?	1. Perform passive range-of-motion maneuvers such as wrist shaking, elbow flexion-extension, and arm drop tests. 2. The acute phase typically presents with flaccid hypotonia or weakness, which progressively transitions into spastic hypertonia (clasps-knife phenomenon) in the chronic phase.
4. How is deep tendon reflex (DTR) asymmetry evaluated, and what does it signify in the context of acute infantile hemiplegia?	1. Compare reflexes (biceps, triceps, knee jerks, ankle jerks) side-by-side using consistent percussion force. 2. Initially, DTRs may be depressed or absent during the acute spinal shock phase, but they characteristically become hyperactive with clonus on the hemiplegic side as spasticity develops.
5. What specific inspection finding in the eyes is critical when examining a child with suspected intracranial hypertension accompanying hemiplegia?	1. Perform a direct fundoscopic examination to evaluate for papilledema, retinal hemorrhages, or cherry-red spots. 2. Papilledema indicates raised intracranial pressure, which may be seen in cerebral venous sinus thrombosis, mass lesions, or malignant infarcts, whereas retinal hemorrhages suggest non-accidental head injury.
6. VIVA TRAP: N. VIVA TRAP: Can the absence of an asymmetrical abdominal reflex definitively rule out a spinal or cortical lesion in an infant presenting with acute weakness?	NO. Abdominal reflexes are physiologically unreliable and often unelicited or absent in infants and toddlers under the age of 2. Therefore, their absence cannot be used as a reliable localization sign for corticospinal pathology in this age group.
7. What bedside technique is used to assess superficial abdominal reflexes in an older child with acute hemiplegia, and what is the pathological significance?	1. Lightly stroke the abdominal wall quadrants toward the umbilicus using a blunt applicator. 2. Absence of the abdominal reflex on the side contralateral to the hemisphere lesion is an early localizing sign of pyramidal tract involvement.
8. What specific inspection and palpation findings of the neck must be documented to identify potential cervical arterial dissection?	1. Inspect and palpate the neck for swelling, tenderness, hematoma, or reluctance to move the cervical spine. 2. Localized tenderness or soft tissue swelling along the carotid or vertebral path following minor trauma strongly suggests cervical artery dissection leading to secondary stroke.
9. How is the Barré and Mingazzini test modified and performed for lower limb evaluation in a young child with suspected hemiplegia?	1. Observe the child lying prone or supine while attempting to keep the lower limbs elevated against gravity (e.g., holding knees at a 90-degree angle). 2. Rapid downward sagging of the affected leg compared to the normal side signifies subtle lower extremity pyramidal weakness.
10. VIVA TRAP: N. VIVA TRAP: Is the presence of normal, symmetrical neonatal primitive reflexes (like the Moro reflex) sufficient to exclude acute hemiplegia in an infant?	NO. Primitive reflexes can remain intact or symmetric initially, especially if the subcortical structures are spared or if the lesion is small and restricted to the cortical convexity; upper motor neuron signs manifest as evolving asymmetry and spasticity.
11. What specific cranial nerve examination finding helps differentiate a cortical stroke from a brainstem lesion in an infant with acute hemiplegia?	1. Check for crossed cranial nerve palsies (e.g., lower motor neuron cranial nerve palsy on one side with contralateral hemiplegia). 2. A crossed deficit indicates a brainstem lesion (e.g., Weber syndrome), whereas an uncrossed, purely supratentorial pattern points to a middle cerebral artery cortical/subcortical infarct.
12. How do you clinically examine for forced conjugate deviation of the eyes ("gaze preference") in a child with acute hemispheric stroke?	1. Observe the resting position and voluntary tracking of the eyes; note if the eyes are persistently deviated away from the weak side (looking at the lesion). 2. Gaze preference toward the side of the cerebral lesion is a hallmark sign of acute large-vessel anterior circulation ischemia or destructive frontal eye field damage.
13. VIVA TRAP: N. VIVA TRAP: Can the presence of normal deep tendon reflexes in the acute stage of motor weakness completely rule out an acute structural vascular stroke?	NO. In the immediate hyperacute and acute phase of an ischemic stroke, the affected limbs frequently exhibit hypotonia and depressed or absent reflexes due to neurological "spinal/cerebral shock" before hyperreflexia and spasticity develop over subsequent days.
14. How does the pattern of facial nerve involvement help clinically differentiate an upper motor neuron (UMN) hemiplegia from a lower motor neuron (LMN) facial palsy in an infant presenting with acute hemiplegia?	1. In UMN acute infantile hemiplegia, there is central facial weakness characterized by sparing of the upper face (forehead wrinkling and eye closure are intact) with drooping of the lower face on the affected side. 2. LMN facial palsy involves both the upper and lower face equally (inability to close the eye tightly or wrinkle the forehead). 3. Always observe the infant during crying or smiling, as facial asymmetry becomes much more pronounced with emotional facial movements.
15. What bedside reflex evaluation technique demonstrates an upper motor neuron lesion in an infant who is too young to exhibit a classic adult Babinski sign?	1. In infants under 12 months, the plantar response can normally be extensor, so examiners rely on alternative pyramidal signs such as Oppenheim, Gordon, or Chaddock reflexes. 2. Asymmetry of deep tendon reflexes (hyperreflexia on the hemiplegic side) combined with an absent superficial abdominal reflex on the corresponding side confirms a corticospinal tract lesion. 3. Eliciting clonus at the ankle or patella provides definitive bedside evidence of hyper-excitability of the spinal reflex arc secondary to an acute cerebral insult.
16. VIVA TRAP: 4. VIVA TRAP: Can the presence of normal, symmetric primitive reflexes (like the Moro or palmar grasp reflex) completely rule out an acute structural motor pathway lesion in a 3-month-old infant presenting with acute hemiplegia?	NO. Primitive reflexes are mediated subcortically and can remain symmetric or intact initially during the acute phase of a unilateral cerebral infarction or hemorrhage, even when distinct focal motor weakness is present upon careful inspection of spontaneous limb movements.
17. What specific bedside observation of spontaneous limb movements (the "arm drop" or "leg drop" test) helps diagnose subtle hemiparesis in an uncooperative infant?	1. Lift both upper limbs or lower limbs simultaneously off the examination table and release them abruptly while observing the speed and posture of descent. 2. The paretic limb falls more heavily, flaccidly, and rapidly than the normal limb, often assuming a pronated or externally rotated posture. 3. Comparing spontaneous antigravity movements (such as reaching or kicking) during tickling or visual tracking uncovers asymmetry when formal strength grading is impossible.

Diagnostic Criteria & Investigations

Question	Answer
1. What specific MRI sequence is most sensitive for detecting early cytotoxic edema and acute ischemia in pediatric stroke?	Diffusion-Weighted Imaging (DWI), which shows high signal intensity coupled with corresponding low signal on the Apparent Diffusion Coefficient (ADC) map.
2. Why is non-contrast computed tomography (NCCT) of the brain still considered the initial emergency imaging of choice in acute infantile hemiplegia?	NCCT is rapidly accessible and primarily used in the emergency setting to urgently rule out intracranial hemorrhage, large space-occupying lesions, or mimics before considering other interventions.
3. What non-invasive vascular imaging modality should be performed alongside brain MRI to evaluate cerebral arteriopathy in children?	Magnetic Resonance Angiography (MRA) of the intracranial and neck vessels is essential to visualize large-vessel occlusion, stenosis, or arterial dissection.
4. VIVA TRAP: N. VIVA TRAP: Can a normal initial non-contrast CT scan of the brain safely rule out an acute ischemic stroke in a child presenting with sudden hemiplegia?	NO. NCCT frequently appears completely normal in the first 12 to 24 hours of an acute arterial ischemic stroke; therefore, a normal CT does not exclude ischemia and requires MRI confirmation.
5. What essential baseline hematological investigations are mandatory in the immediate evaluation of acute infantile hemiplegia?	Complete blood count (CBC) with platelet count, peripheral smear to look for sickle cells or schistocytes, and inflammatory markers (CRP/ESR) to screen for infection or systemic inflammation.
6. Which metabolic screening tests should be ordered as part of the primary diagnostic workup for unexplained acute stroke in an infant?	Serum lactate, pyruvate, plasma ammonia, venous blood gas, and tandem mass spectrometry (TMS) for aminoacidopathies and organic acidurias.
7. What is the recommended timeframe and panel for evaluating inherited and acquired prothrombotic states in pediatric stroke?	Thrombophilia workup should ideally be delayed until the acute phase resolves, including protein C, protein S, antithrombin III, factor V Leiden mutation, prothrombin gene mutation, and antiphospholipid antibodies.
8. How does Transcranial Doppler (TCD) ultrasonography aid in the investigation of acute stroke or cerebral vasculopathy in infants?	TCD assesses blood flow velocities in the major intracranial arteries (such as the middle cerebral artery), helping detect stenosis, vasospasm, or abnormal flow patterns, especially in conditions like sickle cell disease.
9. What specific cerebrospinal fluid (CSF) findings are expected if acute infantile hemiplegia is secondary to acute bacterial meningitis or meningoencephalitis?	CSF analysis typically shows pleocytosis (neutrocytic or lymphocytic), elevated protein, decreased glucose (in bacterial infection), and positive Gram stain or multiplex PCR panels.
10. What radiological sign on brain MRI or CT helps differentiate cerebral sinovenous thrombosis (CSVT) from arterial ischemic stroke?	The "dense triangle sign" or "cord sign" on non-contrast CT, along with lack of flow voids and absence of enhancement on MR Venography (MRV), confirms CSVT.
11. What diagnostic modality is considered the gold standard for defining complex intracranial vasculopathies like focal cerebral arteriopathy or moyamoya disease?	Digital Subtraction Angiography (DSA) remains the gold standard vascular imaging technique, providing superior spatial resolution for small vessel anatomy compared to MRA.
12. What serum biomarker cutoff or elevation points toward mitochondrial cytopathy (such as MELAS) in a child presenting with stroke-like episodes?	Markedly elevated resting blood lactate (often > 2.5 mmol/L) and an elevated CSF-to-blood lactate ratio strongly support a mitochondrial etiology.
13. What specific electrocardiographic (ECG) and echocardiographic investigations are mandatory to rule out a cardioembolic source in acute infantile stroke?	A 12-lead ECG and a transthoracic echocardiography (TTE) with bubble study are mandatory to detect congenital heart defects, intracardiac thrombi, vegetations, or patent foramen ovale (PFO).
14. What screening test is essential in an Indian infant presenting with acute hemiplegia to rule out hemoglobinopathies like sickle cell disease?	High-Performance Liquid Chromatography (HPLC) or a sickling test is mandatory, as sickle cell disease is a major cause of pediatric stroke in endemic regions.
15. How does Gradient Echo (GRE) or Susceptibility-Weighted Imaging (SWI) assist in evaluating acute stroke presentations?	SWI/GRE sequences are exquisitely sensitive in detecting microhemorrhages, hemorrhagic transformation of an infarct, or underlying vascular malformations and cavernomas.
16. VIVA TRAP: N. VIVA TRAP: Can a normal erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) completely exclude primary CNS vasculitis in a child with stroke?	NO. Primary angiitis of the CNS (PACNS) often presents with entirely normal systemic inflammatory markers (ESR and CRP) because the inflammation is confined strictly to the cerebral vasculature.
17. What specialized autoimmune and infectious serology panel is indicated when cerebral vasculitis is suspected in acute infantile hemiplegia?	Antinuclear antibodies (ANA), anti-double-stranded DNA, anti-neutrophil cytoplasmic antibodies (ANCA), lupus anticoagulant, and serology for infections like syphilis, Lyme disease, and tuberculosis.
18. What is the modality of choice and specific neuroimaging protocol required to definitively differentiate arterial ischemic stroke from cerebral sinovenous thrombosis and structural mimics in acute infantile hemiplegia?	1. Magnetic Resonance Imaging (MRI) combined with Magnetic Resonance Angiography (MRA) and Venography (MRV) is the gold standard investigation. 2. Essential sequences include diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps to confirm acute restricted diffusion, alongside T2/FLAIR and gradient echo (GRE/SWI) sequences to rule out hemorrhage.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What are the immediate emergency stabilization priorities in the first 10 minutes for an infant presenting with acute hemiplegia?	1. Ensure Airway, Breathing, and Circulation (ABC stabilization). 2. Maintain normoglycemia and normothermia. 3. Administer supplemental oxygen only if oxygen saturation drops below 94%.
2. How should acute symptomatic seizures be managed in a child presenting with acute infantile hemiplegia?	1. Administer intravenous lorazepam (0.1 mg/kg) or diazepam (0.2-0.3 mg/kg) as first-line abortive therapy. 2. Follow immediately with a loading dose of levetiracetam (60 mg/kg IV) or phenytoin (20 mg/kg IV) to prevent status epilepticus.
3. What is the role and dosing regimen of acute antithrombotic therapy with unfractionated heparin (UFH) in confirmed pediatric arterial ischemic stroke?	1. UFH is initiated after intracranial hemorrhage is ruled out via neuroimaging. 2. Dosed with an initial IV bolus of 75 units/kg followed by a continuous infusion of 20 units/kg/hour, targeting an activated partial thromboplastin time (aPTT) of 60 to 85 seconds.
4. What is the precise pharmacological role and maintenance dosage of low-molecular-weight heparin (LMWH) such as enoxaparin in pediatric stroke?	1. Enoxaparin acts by inhibiting factor Xa and thrombin via antithrombin. 2. Administered subcutaneously at 1 mg/kg every 12 hours in infants and children, targeting anti-Xa levels of 0.5 to 1.0 IU/mL.
5. When is antiplatelet therapy preferred over anticoagulation, and what is the standard pediatric dosage for aspirin?	1. Antiplatelet therapy is preferred for non-cardioembolic arterial ischemic stroke and primary stroke prevention in sickle cell disease. 2. Low-dose aspirin is administered at 1 to 5 mg/kg/day orally once daily.
6. What are the specific therapeutic indications and protocols for acute exchange transfusion or simple top-up transfusion in an Indian child with sickle cell disease presenting with acute stroke?	1. Indicated to rapidly reduce the fraction of hemoglobin S (HbS) below 30% and improve cerebral oxygen delivery. 2. Performed via automated erythrocytapheresis or simple top-up packed red blood cell transfusion keeping total hemoglobin below 10 g/dL to avoid hyperviscosity.
7. What is the stepwise pharmacological approach to managing acute raised intracranial pressure (ICP) secondary to malignant middle cerebral artery infarction?	1. Elevate head of the bed to 30 degrees and maintain neutral neck alignment. 2. Administer osmotic therapy with 20% mannitol (0.5–1 g/kg IV over 20 minutes) or hypertonic saline 3% (3–5 mL/kg IV).
8. What is the mechanism of action and clinical indication for administering corticosteroids in pediatric acute infantile hemiplegia?	1. Corticosteroids like methylprednisolone (30 mg/kg/day IV) are indicated exclusively if an inflammatory CNS vasculitis, ADEM, or neurosarcoidosis is diagnosed. 2. They exert profound anti-inflammatory and immunosuppressive actions but are contraindicated in pure ischemic stroke.
9. VIVA TRAP: N. VIVA TRAP: Should recombinant tissue plasminogen activator (rt-PA) be administered routinely to infants presenting within the golden 4.5-hour window of acute arterial ischemic stroke?	NO. Intravenous thrombolysis with rt-PA is not routinely recommended in pediatric stroke outside of carefully controlled clinical trials due to limited safety data and high baseline rates of non-atherosclerotic arteriopathies.
10. What specific laboratory parameters and monitoring schedule are mandatory during therapeutic anticoagulation with LMWH or unfractionated heparin in infants?	1. Monitor anti-Xa levels 4 hours post-dose for LMWH or aPTT for UFH. 2. Perform baseline and serial platelet counts twice weekly to monitor for heparin-induced thrombocytopenia (HIT).
11. What are the precise surgical indications and procedures for life-saving decompressive craniectomy in a child with malignant cerebral infarction?	1. Indicated for impending uncal herniation, rapid neurological deterioration, and massive edema involving greater than 50% of the middle cerebral artery territory refractory to medical therapy. 2. Procedure involves large frontotemporoparietal decompressive craniectomy with expansive duraplasty.
12. What specific multidisciplinary rehabilitation therapies must be initiated immediately after the acute phase stabilization of infantile hemiplegia?	1. Constraint-Induced Movement Therapy (CIMT) to promote functional recovery of the affected upper limb. 2. Comprehensive physical, occupational, and speech therapy initiated as soon as the patient is medically stable.
13. What long-term pharmacological management is indicated for children with acute hemiplegia secondary to documented cardioembolic sources (such as cyanotic heart disease or prosthetic valves)?	1. Long-term anticoagulation with LMWH transitioning to oral Vitamin K antagonists (Warfarin targeting an INR of 2.0 to 3.0) or age-appropriate direct oral anticoagulants (DOACs).
14. VIVA TRAP: N. VIVA TRAP: Can non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen be safely used as first-line agents for post-stroke headache in children receiving antiplatelet therapy?	NEVER. NSAIDs should be strictly avoided or used with extreme caution in children on antiplatelet or anticoagulant therapy due to the additive risk of gastrointestinal bleeding and systemic hemorrhage.
15. What specific nutritional and metabolic considerations must be prioritized during the acute and subacute recovery phases of pediatric stroke?	1. Assess for dysphagia via formal swallowing screening prior to initiating oral feeds to prevent aspiration pneumonia. 2. Ensure adequate enteral or parenteral caloric and hydration support, utilizing nasogastric tube feeding if swallowing is compromised.
16. What targeted medical therapy is utilized for children who develop progressive cerebral arteriopathy (FCA) following an acute ischemic stroke?	1. Short-course tapering regimens of corticosteroids combined with antiplatelet therapy are frequently employed to suppress active arterial inflammation. 2. Regular angiographic surveillance (MRA or CTA) is mandatory to assess arteriopathy progression and evaluate the need for surgical revascularization.
17. What is the specific therapeutic role and dosage of calcium channel blockers, specifically flunarizine, in the long-term prophylaxis of Alternating Hemiplegia of Childhood (AHC)?	1. Flunarizine, a selective calcium entry blocker, is the drug of choice for reducing the frequency, severity, and duration of paroxysmal hemiplegic and dystonic attacks in AHC. 2. It is initiated at a standard pediatric dose of 5 to 10 mg once daily at bedtime (for children under 40 kg, usually 0.5 mg/kg/day). 3. Treatment requires close surveillance for side effects including weight gain, excessive sedation, depression, and extrapyramidal symptoms.
18. VIVA TRAP: N. VIVA TRAP: Can therapeutic plasmapheresis or intravenous immunoglobulin (IVIG) be routinely recommended as primary empirical treatment for acute ischemic stroke secondary to non-inflammatory focal cerebral arteriopathy?	NO. Therapeutic plasma exchange and IVIG are not indicated for non-inflammatory focal cerebral arteriopathy (FCA) unless there is definitive, biopsy-proven evidence of primary CNS vasculitis (PCNSV) or secondary immune-mediated vasculitis. Empirical immunomodulatory therapy carries significant infection risks and provides no proven benefit in non-inflammatory arteriopathies.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: N. VIVA TRAP: Can a child presenting with acute alternating hemiplegia of childhood (AHC) be managed with standard acute stroke reperfusion or antithrombotic protocols?	NEVER. AHC is a genetic channelopathy caused by ATP1A3 mutations where acute motor attacks do not represent vascular occlusion; administering anticoagulants or antiplatelets is completely ineffective and increases bleeding risks.
2. VIVA TRAP: N. VIVA TRAP: Is routine hyperventilation a recommended acute intervention for reducing intracranial pressure in an infant with malignant hemispheric infarction?	NEVER. Prophylactic hyperventilation causes severe cerebral vasoconstriction, worsening ischemia and exacerbating the core infarct volume in children.
3. VIVA TRAP: What is the immediate pharmacological countermeasure when an infant develops heparin-induced bleeding complications during UFH therapy for cerebral sinovenous thrombosis?	Protamine sulfate should be administered intravenously to neutralize unfractionated heparin, calculated at 1 mg per 100 units of heparin given in the preceding 2 to 4 hours.
4. VIVA TRAP: N. VIVA TRAP: Can oral vitamin K antagonists (such as warfarin) be safely initiated as first-line outpatient therapy in infants under 1 year with cardioembolic stroke?	NEVER. Infants have significantly lower levels of vitamin K-dependent clotting factors and immature proteins C and S, making warfarin highly unpredictable and difficult to monitor; LMWH is preferred.
5. VIVA TRAP: What specific dietary restriction is mandatory for children diagnosed with classic homocystinuria presenting with acute arterial ischemic stroke?	A methionine-restricted, cysteine-supplemented diet combined with high-dose pyridoxine (vitamin B6) and betaine supplementation to lower plasma homocysteine levels.
6. VIVA TRAP: N. VIVA TRAP: Should therapeutic lumbar puncture be performed to reduce intracranial pressure in an infant with acute cerebral sinovenous thrombosis and papilledema?	NEVER. Aggressive CSF removal via lumbar puncture in the presence of large dural sinus thrombosis can precipitate fatal transtentorial or tonsillar herniation due to a pressure gradient.
7. VIVA TRAP: What is the precise fluid restriction formula recommended during the acute phase of severe ischemic stroke with cerebral edema?	Maintenance intravenous fluids should be restricted to 70% to 80% of calculated daily requirements using isotonic solutions like normal saline, strictly avoiding hypotonic fluids (like 0.45% saline or 5% dextrose) to prevent cerebral edema.
8. VIVA TRAP: What specific emergency management protocol is indicated if a child with acute hemiplegia secondary to a ruptured arteriovenous malformation (AVM) develops sudden Cushing triad?	Immediate neurosurgical consultation for external ventricular drain (EVD) placement or hematoma evacuation, osmotic diuresis with 20% mannitol (0.5 to 1 g/kg), and controlled normocapnia via mechanical ventilation.
9. VIVA TRAP: What is the definitive management protocol for an infant presenting with acute hemiplegia caused by severe dehydration and hypernatremic dehydration stroke?	Slow, controlled rehydration over 48 hours using isotonic fluids to gradually lower serum sodium by no more than 0.5 to 1 mmol/L per hour, preventing cerebral edema and osmotic demyelination.
10. VIVA TRAP: N. VIVA TRAP: Should hyperbaric oxygen therapy (HBOT) be utilized as an acute neuroprotective intervention in pediatric arterial ischemic stroke?	NEVER. There is no high-level clinical trial evidence supporting HBOT in pediatric stroke, and transfer of an unstable, critically ill infant to a hyperbaric chamber carries extreme safety hazards.
11. VIVA TRAP: What is the recommended management strategy for accidental over-anticoagulation with enoxaparin resulting in active systemic hemorrhage in an infant?	Administer slow intravenous protamine sulfate (1 mg per 1 mg of enoxaparin given in the last 8 hours), recognizing that protamine only partially neutralizes anti-Xa activity (about 60% to 75%).
12. VIVA TRAP: N. VIVA TRAP: Can routine osmotic agents like glycerol or urea be administered orally to manage intracranial hypertension in infants with acute stroke?	NEVER. Oral glycerol can cause severe hemolysis, electrolyte disturbances, and unpredictable absorption in infants; intravenous mannitol or hypertonic saline are the agents of choice.
13. VIVA TRAP: What immediate intervention is required when a child with sickle cell disease and acute stroke presents with acute chest syndrome on chest radiography?	Immediate simple top-up transfusion or automated red blood cell exchange transfusion, coupled with broad-spectrum intravenous antibiotics, supplemental oxygen, and aggressive pain management.
14. VIVA TRAP: N. VIVA TRAP: Should routine prophylactic anticonvulsants (like levetiracetam or phenytoin) be prescribed to every child immediately following an ischemic stroke to prevent future epilepsy?	NEVER. Prophylactic antiepileptic drugs do not prevent the development of post-stroke epilepsy and expose the child to unnecessary drug toxicity; treat only acute symptomatic seizures.
15. VIVA TRAP: What specific blood pressure management target must be maintained during the acute phase of pediatric ischemic stroke unless malignant hypertension is present?	Blood pressure must be maintained strictly within the age-appropriate normal percentiles (between 50th and 90th percentiles); aggressive lowering can precipitate infarct expansion, while allowing severe hypertension risks hemorrhage.
16. VIVA TRAP: N. VIVA TRAP: Can diagnostic lumbar puncture be safely performed immediately in an infant presenting with acute infantile hemiplegia and suspected meningoencephalitis without prior neuroimaging?	NEVER. Lumbar puncture must never be performed prior to neuroimaging (CT or MRI brain) in a child presenting with acute focal neurological deficits and hemiplegia, as severe mass effect, focal cerebral edema, or malignant infarction can precipitate fatal uncal or tonsillar herniation.
17. VIVA TRAP: N. VIVA TRAP: Should systemic therapeutic anticoagulation with LMWH or unfractionated heparin be immediately initiated upon detecting a small hemorrhagic transformation within an acute ischemic stroke territory on initial brain imaging?	NO. Anticoagulation is strictly contraindicated in the presence of hemorrhagic transformation of an ischemic stroke or primary intracranial hemorrhage, as it significantly worsens bleeding risk; supportive care and blood pressure optimization must take precedence.